Renal Cancer
The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications.
May 16, 2019
FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma.
May 16, 2019